Artivion, Inc. (AORT)
$21.53+0.80%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.0B
- Beta
- 1.22
- P/E (TTM)
- -361.24
- Short % float
- 7.86%
- Days to cover
- 5.5
- SI change
- +10.3%
- 1W
- -0.37%
- 1M
- -15.17%
- vs SPY 1W
- +0.61%
- vs SPY 1M
- -17.03%
Industry peers
FMP comparable companies · ranked by market cap
- COGTSELLCogent Biosciences, Inc.$5.3BCRISISQ 12$31.00+0.21%
- LFSTSELLLifeStance Health Group, Inc.$4.8BBEARQ -5$12.42+1.62%
- ITGRBUYInteger Holdings Corporation$4.3BBULLQ 19$126.61+0.02%
- LQDASELLLiquidia Corporation$2.4BCRISISQ 14$27.38+26.59%
- BKDSELLBrookdale Senior Living Inc.$2.4BCRISISQ 5$10.12-0.10%
- ADUSSELLAddus HomeCare Corporation$2.1BBEARQ 18$114.33+1.82%
- INSPSELLInspire Medical Systems, Inc.$2.0BRECOVERYQ 13$68.89-1.15%
- ARDTBUYArdent Health Inc.$1.6BRECOVERYQ -11$11.30+2.22%
- PRCTSELLPROCEPT BioRobotics Corporation$1.0BCRISISQ -4$18.40-8.32%
- SSIISELLSS Innovations International, Inc.$529MCRISISQ 16$2.65+5.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on AORT?
- LOPJLB’s latest quantitative signal on Artivion, Inc. (AORT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AORT in?
- Artivion, Inc. (AORT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Artivion, Inc. (AORT) do?
- Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine per…